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The diagnostic value of serum concentrations of 2-(a-
mannopyranosyl)-L-tryptophan for normal renal function.
Background. We have previously reported that the serum
concentration of 2-(a-mannopyranosyl)-L-tryptophan (MPT),
tryptophan glycoconjugate, is a more accurate measure of renal
function than that of serum creatinine concentration. The aim
of the present study was to compare the diagnostic value of
serum concentrations of MPT and creatinine as a measure of
normal renal function.
Methods. A total of 156 subjects with serum creatinine con-
centration ≤1.60 mg/dL aged 0 to 88 years were recruited.
Serum concentrations of MPT and creatinine, and creatinine
clearance calculated by Cockcroft-Galt formula were deter-
mined. A diagnostic accuracy of serum concentrations of MPT
and creatinine for normal renal function was analyzed by us-
ing receiver-operating characteristics (ROC) curves. In 82 sub-
jects with normal renal function defined as calculated creatinine
clearance ≥80 mL/min (aged 6 to 68 years), the correlations be-
tween age and/or urinary creatinine excretion, which is related
to muscle mass, and serum concentrations of MPT or creatinine,
were determined.
Results. In the ROC curve, the area under the curve (AUC) in
serum MPT concentration was significantly greater than that of
creatinine (0.855 versus 0.800, respectively, P < 0.001) and the
cut-off levels associated with the greatest diagnostic accuracy
were 90 ng/mL for serum MPT concentration and 0.70 mg/dL
for serum creatinine concentration. The sensitivity, specificity,
and positive and negative predictive values were 69.5%, 85.1%,
83.8%, and 71.6% for serum MPT concentration, and 53.7%,
81.1%, 75.9%, and 61.2% for serum creatinine concentration.
A close correlation existed between serum creatinine concen-
tration and age (r = 0.798, P < 0.0001) in 23 subjects aged
20 years or younger. Conversely, serum MPT concentration re-
mained unchanged regardless of age (r = −0.135, P = 0.228).
Furthermore, a close correlation existed between serum creati-
nine concentration and urinary creatinine excretion (r = 0.817,
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P < 0.0001), but not between serum MPT concentration and
urinary creatinine excretion (r = 0.082, P = 0.461).
Conclusion. The concentration of serum MPT is a more re-
liable diagnostic parameter than that of serum creatinine as a
measure of normal renal function, and renal function can be
compared in subjects independently of age and muscle mass
when serum MPT concentration is measured.
An accurate measure of renal function is of great im-
portance in assessing the progression of chronic renal
failure and in determining the initiation of renal replace-
ment therapy. Serum creatinine concentration is widely
used for assessing renal function in the clinical setting, be-
cause of its speed and simplicity. However, as it is greatly
influenced by muscle mass as well as renal function [1–3],
the measurement of serum creatinine concentration can
be prone to misinterpretation of the results in subjects
with diminished muscle mass, such as the elderly, chil-
dren, and females. Thus, the measurement of serum cre-
atinine concentration may overestimate renal function in
these populations.
This shortcoming can be overcome by measuring with
serum 2-(a-mannopyranosyl)-L-tryptophan (MPT) con-
centration. We have previously reported that the serum
concentration of MPT is an accurate measure of renal
function even in subjects with diminished muscle mass
and a better indicator of renal function than serum crea-
tinine concentration [4]. MPT, isolated from human urine
[2], is a stable substance with a molecular weight of 366 D.
This substance has been demonstrated to be a trypto-
phan c-glycoside and to be characterized by a sugar moi-
ety bound to the carbon [3]. The structure of MPT is
illustrated in Figure 1. MPT is found in serum and cere-
brospinal fluid [2]. Although its metabolism and phys-
iologic role remain to be clarified, our previous report
has shown that MPT clearance is almost identical to in-
ulin clearance in experimental animals, indicating a sim-
ilar renal handling of the two molecules [4]. The aim of
the present study was to compare the diagnostic value of
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Fig. 1. Structure of 2-(a-mannopyranosyl)-L-tryptophan (MPT).
serum concentrations of MPT and creatinine as a mea-
sure of normal renal function.
METHODS
Study design
To compare the diagnostic accuracy of serum concen-
trations of MPT and creatinine as normal renal function
using receiver-operating characteristic (ROC) curve, we
recruited 156 subjects (69 men and 87 women) with serum
concentration of ≤1.60 mg/dL between 1999 and 2001.
Informed consent was obtained from adult subjects, and
from a family member of the subjects in case of children.
The present study was approved by the local ethics com-
mittee. Among these 156 subjects, we identified 82 sub-
jects with normal renal function (34 men and 48 women).
Correlations of age or urinary creatinine excretion, which
is related to muscle mass [5], with serum concentrations
of creatinine or MPT were also determined. Creatinine
clearance was calculated by Cockcroft-Gault formula [6],
and normal renal function was defined by calculated as
creatinine clearance ≥80 mL/min.
ROC
A diagnostic value for normal renal function, defined
as calculated creatinine clearance ≥80 mL/min [7–9], was
compared between serum concentrations of MPT and
creatinine by using ROC curves [10], in which the sen-
sitivity of the test is plotted against the 1-specificty over
all possible decision values and ROC plot area under the
curve (AUC) measured against the reference standard.
ROC plot AUC analysis is an effective way to determine
which test offers the best overall clinical performance and
is widely used to show limits of a test’s ability to discrim-
inate state of normal value versus abnormal value.
Measurements
Values of urinary creatinine excretion were determined
as the mean of three-consecutive days in 24-hour urine
collection. Creatinine concentrations in serum and urine
were determined by enzymatic method using a Hitachi
7350 autoanalyzer (Hitachi, Tokyo, Japan). Serum MPT
concentration was determined by high-performance liq-
uid chromatography (HPLC), using a modified method
from that of our previous report [4]. In brief, 500 lL of
serum was mixed with 350 lL of cold hydrogen chloride
solution (0.1 mol/L) and ascorbic acid (10 g/L) and 100 lL
of 60% perchloric acid. This mixture was centrifuged at
2000g for 7 minutes at 4◦C. Supernatant was then filtered
through a 0.45 lm membrane filter. A 100 lL aliquot
of the filtrate was used for HPLC analysis. The HPLC
system consisted of a model L-7100 pump (Hitachi), a
model L-7250 programmable autosampler (Hitachi), a
model L-7300 column oven (Hitachi), a model L-7485 flu-
orescence detector (Hitachi), and a model D-7000 HPLC
systemmanager (Hitachi). A 4.6 mm × 25 cm column
prepared with Shimpack HRC-ODS (5 lm particle size)
(Shimadzu, Kyoto, Japan) was used. Creatinine clearance
was adjusted to a body surface of 1.73 m2.
Statistical analyses
All data are expressed as mean ± SD. Correlations
among data were examined by simple regression analy-
sis. The sensitivity, specificity and positive and negative
predictive values for different cut-off levels were calcu-
lated according standard formula as follows:
Sensitivity = (number of subjects with normal renal func-
tion and value ≤ cut-off)/(total number of subjects with
normal renal function);
Specificity = (number of subjects without normal renal
function and value > cut-off)/(total number of subjects
without normal renal function);
Positive predictive value = (number of subjects with nor-
mal renal function and value ≤ cut-off)/(total number
of subjects with value ≤ cut-off); and
Negative predictive value = (number of subjects with-
out normal renal function and value > cut-off)/(total
number of subjects with value > cut-off).
A P value less than 0.05 was considered statistically
significant. Analyses were performed using a standard
software package (StatMate III, Atoms Co., Ltd., Tokyo,
Japan).
RESULTS
Clinical characteristics of 156 subjects recruited are
shown in Table 1. The age of these subjects ranged be-
tween 0 and 88 years (40.9 ± 20.7 years), and calculated
creatinine clearance between 14.8 and 259.6 mL/min
(86.6 ± 37.9 mL/min). The ROC curves were used to
evaluate the diagnostic values of serum concentrations
of MPT and creatinine (Fig. 2). The AUC of serum MPT
concentration resulted in a larger area under the ROC
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Table 1. Clinical characteristics in all subjects
Range
Number (men/women) 156 (69/87)
Age years 40.9 ± 20.7 0–88
Serum MPT ng/mL 163.4 ± 41.8 25.0–281.0
Serum creatinine mg/dL 0.84 ± 0.33 0.24–1.59
Calculated creatinine clearance mL/min 86.6 ± 37.9 14.8–259.6
Body mass index kg/m2 21.2 ± 3.6 11.8–30.3
MPT is 2-(a-mannopyranosyl)-L-tryptophan.
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Fig. 2. Receiver-operating characteristics (ROC) curve of serum con-
centrations of 2-(a-mannopyranosyl)-L-tryptophan MPT (• and solid
line) and creatinine (◦ and dotted line).
Table 2. Clinical characteristics in subjects with calculated creatinine
clearance of more than 80 mL/min
Range
Number (men/women) 82 (34/48)
Age years 30.7 ± 16.0 6–68
Serum MPT ng/mL 83.0 ± 20.1 25.0–143.0
Serum creatinine mg/dL 0.67 ± 0.20 0.24–1.19
Calculated creatinine clearance mL/min 114.1 ± 29.6 80.0–259.6
Body mass index kg/m2 21.6 ± 3.5 11.8–30.1
MPT is 2-(a-mannopyranosyl)-L-tryptophan.
curve compared with that of serum creatinine concen-
tration (0.855, 95% CI 0.805 to 0.904 and 0.800, 95% CI
0.740 to 0.860, respectively, P < 0.0001). Cut-off levels
were set as the level that resulted in the optimal diag-
nostic accuracy; 90 ng/mL for serum MPT concentration
and 0.70 mg/dL for serum creatinine concentration. Using
these cut-off levels, the sensitivity, specificity, positive and
negative predictive values were determined to be 69.5%,
85.1%, 83.8%, and 71.6% for serum MPT concentration,
and 53.7%, 81.1%, 75.9%, and 61.2% for serum creati-
nine concentration.
Clinical characteristics of 82 subjects with normal renal
function are shown in Table 2. The age of these subjects
ranged between 6 and 68 years. The mean value of serum
MPT concentration was 83.0 ± 20.1 ng/mL, and the 95%
CIs were 57.0 to 115.0 ng/mL. Correlation of age with
serum concentrations of creatinine and MPT are illus-
trated in Figure 3. Serum creatinine concentration was
positively correlated with age in 23 subjects aged 20 years
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Fig. 3. Correlations of age with serum concentrations of creatinine (A)
and 2-(a-mannopyranosyl)-L-tryptophan MPT (B) in 82 subjects with
calculated creatinine clearance over 80 mL/min. Serum creatinine con-
centration was positively correlated with age in 23 subjects aged 20 years
or less (r = 0.798, P < 0.0001) but not in 59 subjects aged over 21 years
(r = −0.170, P = 0.199). Serum MPT was not correlated with age (r =
−0.135, P = 0.228).
or younger (r = 0.798, P < 0.0001), but not in 59 subjects
aged over 21 years (r = −0.170, P = 0.199). Conversely,
serum MPT concentration was completely uncorrelated
with age (r = −0.135, P = 0.228). Correlations of urinary
creatinine excretion with serum concentrations of crea-
tinine and MPT are illustrated in Figure 4. Serum creati-
nine concentration was positively correlated with urinary
creatinine excretion (r = 0.817, P < 0.0001), while serum
MPT concentration was not correlated with urinary crea-
tinine excretion (r = 0.082, P = 0.461). In addition, serum
creatinine concentration was positively correlated with
body mass index (r = 0.519, P < 0.0001). Conversely,
serum MPT was not correlated with body mass index
(r = 0.079, P = 0.482), as shown in Figure 5.
DISCUSSION
Although the clearances of inulin or 125I-iothalamte are
the standard clinical parameters for the measurement of
glomerular filtration, their measurement is difficult in the
clinical setting. A convenient method in assessing renal
function is to determine serum concentration of an en-
dogenous substance that is not influenced by a variety of
factors other than renal function. Our previous study in
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Fig. 4. Correlations of urinary creatinine excretion with serum con-
centrations of creatinine (A) and 2-(a-mannopyranosyl)-L-tryptophan
MPT (B) in 82 subjects with calculated creatinine clearance over 80
mL/min. Serum creatinine concentration was positively correlated with
urinary creatinine excretion (r = 0.817, P < 0.0001). Serum MPT was
not correlated with urinary creatinine excretion (r = 0.082, P = 0.461).
subjects with a wide range of renal function has demon-
strated that serum concentrations of creatinine and MPT
increased exponentially with the progression of renal dys-
function in the same manner [4]. Furthermore, we have
also demonstrated that serum creatinine concentration is
an inadequate marker for renal function because its mea-
surement is strongly influenced by muscle mass. Serum
creatinine concentration is lower in subjects with urinary
creatinine excretion of <1000 mg/24 hours than those
with urinary creatinine excretion of >1000 mg/24 hours
even at the same renal function and that serum MPT
concentration is similar in subjects with both urinary cre-
atinine excretion of <1000 mg/24 hours and >1000 mg/
24 hours. These findings indicate that serum MPT concen-
tration is not influenced by muscle mass because daily
urinary creatinine excretion is related to muscle mass
[5] and that serum MPT concentration is more adequate
measure for evaluating renal function than that of crea-
tinine. In the present study, the ROC curve for detecting
normal renal function suggested that serum MPT con-
centration was more accurate in assessing normal renal
function than serum creatinine concentration because of
a larger area of AUC under the ROC curve of serum
MPT concentration than that of serum creatinine con-
centration. When the cut-off point for serum MPT con-
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Fig. 5. Correlations of body mass index with serum concentrations of
creatinine (A) and 2-(a-mannopyranosyl)-L-tryptophan MPT (B) in 82
subjects with calculated creatinine clearance over 80 mL/min. Serum
creatinine concentration was positively correlated with body mass index
(r = 0.519, P < 0.0001). Serum MPT was not correlated with urinary
creatinine excretion (r = 0.079, P = 0.482).
centration was 90 mg/mL, sensitivity, specificity and pos-
itive and negative predictive values for detecting normal
renal function were 69.5%, 85.1%, 83.8%, and 71.6%,
respectively. The 95% CIs for serum MPT concentration
in subjects with normal renal function ranged between
57.0 and 115.0 ng/mL. Conversely, sensitivity, specificity
and positive and negative predictive values for detecting
normal renal function were 53.7%, 81.1%, 75.9%, and
61.2%, respectively, when the cut-off point for serum cre-
atinine concentration was 0.70 mg/dL. A meta-analysis
reported recently by Dharnidharka, Kwon, and Stevens
[11] has found that serum cystatin C concentration, an-
other marker for renal function, is superior to serum
creatinine concentration as a marker of normal renal
function. On the basis of these results, the measurement
of serum creatinine concentration can be seen to be not
ideal marker of renal function.
Although the metabolism and the physiologic role of
MPT remain to be clarified, the results in the present
study and our previous study [4] indicate that MPT is
not primarily synthesized in muscle. Because MPT is de-
rived from tryptophan, it is reasonable to hypothesize
that serum MPT concentration may be affected by di-
etary protein intake. However, it has been demonstrated
that the profiles and conformations of this material are
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quite different from those tryptophan conjugates origi-
nating from foods [3].
The finding that serum creatinine concentration is an
inaccurate indicator of normal renal function when com-
pared to serum MPT concentration may be attributed to
the fact that its measurement is influenced by creatinine
production in muscle, dietary creatine intake, filtration
of creatinine through glomeruli, and secretion of creati-
nine through renal tubules. Serum creatinine concentra-
tion remained unchanged in subjects aged over 21 years
with normal renal function, while this value increased in
a linear manner with age in subjects aged 20 years or less
with normal renal function. In addition, serum creatinine
concentration even in subjects with normal renal function
also increased linearly with urinary creatinine excretion
and body mass index. These findings indicate that the nor-
mal range for serum creatinine concentration as a marker
of renal function is altered with age or lean body mass of
the subject. In fact, the decrease in creatinine produc-
tion caused by a loss of lean body mass and the decline
in renal function parallel aging. As a consequence, serum
creatinine concentrations of these subjects are frequently
within the normal range in light of the renal dysfunction
associated with aging [12–14]. In children, the increase
in creatinine production with growth may lead to an in-
crease in serum creatinine concentration even though re-
nal function remains normal. On the other hand, serum
cystatin C concentration has been demonstrated to de-
crease linearly with age in subjects aged 18 months or
less with normal renal function [15].
CONCLUSION
The measurement of serum MPT concentration is a
very useful marker for normal renal function regardless
of the age and muscle mass of the subjects. The normal
range for serum MPT concentration as a measure of nor-
mal renal function is less than 115.0 ng/mL. However,
there are some limitations to the determination of serum
MPT concentration. It can be measured only using the
HPLC method, which is time-consuming and expensive.
A new and more convenient measuring technique is be-
ing developed.
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